公司提供的β-萘酚紫號(hào)：7143-21-7*，貨源充足。嚴(yán)格的生產(chǎn)質(zhì)量控制體系，包括：優(yōu)級純，分析純，化學(xué)純，試劑級，基準(zhǔn)試劑，實(shí)驗(yàn)純，教學(xué)試劑，高純試劑，色譜純，光譜純，電子純。各種包裝規(guī)格，并可提供包裝定制，咨詢訂購。
β-萘酚紫號(hào)：7143-21-7   
英文名稱：β-Naphthol Violet   
其他名稱：4-[[4-(苯甲酰氨基)-2-甲氧基-5-甲基苯基]偶氮]-3-羥基-N-苯基-2-萘甲酰胺   
號(hào)：7143-21-7   
C16H9N3Na2O9S2=497.37   
級別：BR   
Lambda max：508～511nm(H2O)   
Absorbance(E1%1cm)：min. 520(5mg/L, H2O, 508～511nm)   
Drying loss：≤10.0%   
Sensitiveness：Pass   
性狀(以下信息僅供參考)：深紅色或棕色粉末   
用途：本品僅供科研，不得用于其它用途   
保存：RT 客戶根據(jù)β-萘酚紫號(hào)：7143-21-7性質(zhì)、化學(xué)式、分子式、結(jié)構(gòu)式、比重、密度、號(hào)、沸點(diǎn)、熔點(diǎn)、水溶性、MSDS、用途、作用、規(guī)格包裝、性狀、注意事項(xiàng)、英文名、別稱、純度、級別等情況，本產(chǎn)品化學(xué)性質(zhì)穩(wěn)定，運(yùn)輸條件不苛刻，一般儲(chǔ)存在陰涼，干燥，通風(fēng)良好的地方，遠(yuǎn)離不相容的物質(zhì)。保持容器密閉。
試劑品牌：TCI、sigma、Alfa、Avocado、Aldrich、ACROS、Fluka、ICN（MP）等
包裝：1kg、100g、10g、250g、25g、500g、50g、5g等包裝
級別：GR級別、AR級別、CP級別、L.P.級別等

購買須知：
【價(jià)格方面】
每個(gè)時(shí)期原料的價(jià)格都會(huì)波動(dòng)，產(chǎn)品的價(jià)格會(huì)有所升降，以上報(bào)價(jià)僅為參考報(bào)價(jià)！咨詢選購！

【付款方式】
現(xiàn)金，支付寶，銀行轉(zhuǎn)帳，匯款，支票，本票；
請將款項(xiàng)匯至我司公司賬戶（開票的）或者老板的私人賬戶上面，接受支付寶付款；
我司收到款項(xiàng)后會(huì)根據(jù)客戶的相關(guān)要求盡快安排發(fā)貨！

【發(fā)貨時(shí)間】
物流基本上在下午2點(diǎn)之前提交確認(rèn)的訂單，都將盡力安排當(dāng)天發(fā)貨；
如果訂單產(chǎn)品需要拆分及其他特殊情況的要求，則可能會(huì)有一定的延時(shí)。

【配送方式】
確定的訂單后，小貨我司將通過順豐、韻達(dá)等快遞送達(dá)；
大量貨物會(huì)更具情況以德邦、遠(yuǎn)成，普華，中鐵等物流的運(yùn)輸方式發(fā)貨。

【其他服務(wù)】
如您對產(chǎn)品特性及技術(shù)指標(biāo)有特殊要求，我公司可以提供質(zhì)檢單和相關(guān)產(chǎn)品的資料和文件；
如果對產(chǎn)品的包裝或者分裝的有要求的話，也請及時(shí)通知我方，我方好根據(jù)要求盡量滿足您的所需求。

【服務(wù)宗旨】
竭誠提供優(yōu)質(zhì)產(chǎn)品，售后服務(wù)客戶滿意度100％
服務(wù)承諾：工作時(shí)間內(nèi)提供免費(fèi)的技術(shù)咨詢和指導(dǎo) 。我公司的技術(shù)人員都經(jīng)過專業(yè)培訓(xùn)的，將為您提供滿意的產(chǎn)品和真誠的服務(wù)。

Database links : UniProtKB/Swiss-Prot: P50405.1
肺泡表面活性物質(zhì)B（SP-B）也屬糖結(jié)合蛋白家族,參與肺泡表面活性膜的形成和代謝,除在Ⅱ型細(xì)胞中強(qiáng)烈表達(dá)外，在細(xì)支氣管、支氣管上皮內(nèi)也有灶性表達(dá)。SP-B是疏水性蛋白，主要效應(yīng)是促進(jìn)磷脂吸附和分布到肺泡氣-液交界面，促進(jìn)磷脂單分子層的形成，只有這種單分子層磷脂才能使表面張力降低到Z低水平。
英文名稱  Anti-SRC
中文名稱  src原癌基因抗體
別    名  ASV; Avian sarcoma virus; c SRC; CDNA FLJ14219 fis clone NT2RP3003800 highly similar to Rattus norvegicus tyrosine protein kinase pp60 c src mRNA; cSrc; EC 2.7.10.2; Neuronal CSRC tyrosine specific protein kinase; Neuronal SRC; Oncogene SRC; OTTHUMP00000030931; OTTHUMP00000174476; OTTHUMP00000174477; p60 Src; p60-Src; p60Src; pp60c src; pp60c-src; pp60csrc; Proto oncogene tyrosine protein kinase Src; Proto-oncogene c-Src; Proto-oncogene tyrosine-protein kinase Src; Protooncogene SRC; protooncogene SRC Rous sarcoma; Src; SRC Oncogene; SRC_MOUSE; SRC1; Tyrosine kinase pp60c src; Tyrosine protein kinase SRC 1; Tyrosine protein kinase SRC1; v src avian sarcoma (Schmidt Ruppin A2) viral oncogene homolog; V src sarcoma (Schmidt Ruppin A 2) viral oncogene homolog (avian); v src sarcoma (Schmidt Ruppin A 2) viral oncogene homolog avian; vsrc avian sarcoma (Schmidt Ruppin A2) viral oncogene homolog.
濃    度  1mg/1ml
規(guī) 格  0.2ml/200μg
抗體來源  Rabbit 
克隆類型  polyclonal
交叉反應(yīng)  Human, Mouse, Rat, Dog, Cow
產(chǎn)品類型  一抗   
研究領(lǐng)域  腫瘤 細(xì)胞生物 免疫學(xué) 染色質(zhì)和核信號(hào) 神經(jīng)生物學(xué) 信號(hào)轉(zhuǎn)導(dǎo) 激酶和磷酸酶 表觀遺傳學(xué) 
蛋白分子量  predicted molecular weight: 61kDa
性    狀  Lyophilized or Liquid
免 疫 原  KLH conjugated synthetic peptide derived from mouse SRC N-terminus
亞    型  IgG
β-萘酚紫號(hào)：7143-21-7純化方法  affinity purified by Protein A
儲(chǔ) 存 液  0.01M PBS, pH 7.4 with 10 mg/ml BSA and 0.1% Sodium azide
產(chǎn)品應(yīng)用   WB=1:100-500  ELISA=1:500-1000  IP=1:20-100  IHC-P=1:100-500  IHC-F=1:100-500  IF=1:100-500
（石蠟切片需做抗原修復(fù)）
 not yet tested in other applications.
 optimal dilutions/concentrations should be determined by the end user. 
保存條件  Store at -20 °C for one year. Avoid repeated freeze/thaw cycles. The lyophilized antibody is stable at room temperature for at least one month and for greater than a year when kept at -20°C. When reconstituted in sterile pH 7.4 0.01M PBS or diluent of antibody the antibody is stable for at least two weeks at 2-4 °C.
Important Note  This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications.
產(chǎn)品介紹 c-Src tyrosine kinase plays a critical role in signal transduction downstream of growth factor receptors, integrins and G protein-coupled receptors. We used stable isotope labeling with amino acids in cell culture (SILAC) approach to identify additional substrates of c-Src tyrosine kinase in human embryonic kidney 293T cells. We have identified 10 known substrates and interactors of c-Src and Src family kinases along with 26 novel substrates. We have experimentally validated 4 of the novel proteins (NICE-4, RNA binding motif 10, FUSE-binding protein 1 and TRK-fused gene) as direct substrates of c-Src using in vitro kinase assays and cotransfection experiments. Significantly, using a c-Src specific inhibitor, we were also able to implicate 3 novel substrates (RNA binding motif 10, EWS1 and Bcl-2 associated transcription factor) in PDGF signaling. Finally, to identify the exact tyrosine residues that are phosphorylated by c-Src on the novel c-Src substrates, we designed custom peptide microarrays containing all possible tyrosine-containing peptides (312 unique peptides) and their mutant counterparts containing a Tyr --> Phe substitution from 14 of the identified substrates. Using this platform, we identified 34 peptides that are phosphorylated by c-Src. We have demonstrated that SILAC-based quantitative proteomics approach is suitable for identification of substrates of nonreceptor tyrosine kinases and can be coupled with peptide microarrays for high-throughput identification of substrate phosphopeptides.
Function : Non-receptor protein tyrosine kinase which is activated following engagement of many different classes of cellular receptors including immune response receptors, integrins and other adhesion receptors, receptor protein tyrosine kinases, G protein-coupled receptors as well as cytokine receptors. Participates in signaling pathways that control a diverse spectrum of biological activities including gene transcription, immune response, cell adhesion, cell cycle progression, apoptosis, migration, and transformation. Due to functional redundancy between members of the SRC kinase family, identification of the specific role of each SRC kinase is very difficult. SRC appears to be one of the primary kinases activated following engagement of receptors and plays a role in the activation of other protein tyrosine kinase (PTK) families. Receptor clustering or dimerization leads to recruitment of SRC to the receptor complexes where it phosphorylates the tyrosine residues within the receptor cytoplasmic domains. Plays an important role in the regulation of cytoskeletal organization through phosphorylation of specific substrates such as AFAP1. Phosphorylation of AFAP1 allows the SRC SH2 domain to bind AFAP1 and to localize to actin filaments. Cytoskeletal reorganization is also controlled through the phosphorylation of cortactin (CTTN). When cells adhere via focal adhesions to the extracellular matrix, signals are transmitted by integrins into the cell resulting in tyrosine phosphorylation of a number of focal adhesion proteins, including PTK2/FAK1 and paxillin (PXN). In addition to phosphorylating focal adhesion proteins, SRC is also active at the sites of cell-cell contact adherens junctions and phosphorylates substrates such as beta-catenin (CTNNB1), delta-catenin (CTNND1), and plakoglobin (JUP). Another type of cell-cell junction, the gap junction, is also a target for SRC, which phosphorylates connexin-43 (GJA1). SRC is implicated in regulation of pre-mRNA-processing and phosphorylates RNA-binding proteins such as KHDRBS1. Also plays a role in PDGF-mediated tyrosine phosphorylation of both STAT1 and STAT3, leading to increased DNA binding activity of these transcription factors. Involved in the RAS pathway through phosphorylation of RASA1 and RASGRF1. Plays a role in EGF-mediated calcium-activated chloride channel activation. Required for epidermal growth factor receptor (EGFR) internalization through phosphorylation of clathrin heavy chain (CLTC and CLTCL1) at 'Tyr-1477'. Involved in beta-arrestin (ARRB1 and ARRB2) desensitization through phosphorylation and activation of ADRBK1, leading to beta-arrestin phosphorylation and internalization. Has a critical role in the stimulation of the CDK20/MAPK3 mitogen-activated protein kinase cascade by epidermal growth factor. Might be involved not only in mediating the transduction of mitogenic signals at the level of the plasma membrane but also in controlling progression through the cell cycle via interaction with regulatory proteins in the nucleus. Plays an important role in osteoclastic bone resorption in conjunction with PTK2B/PYK2. Both the formation of a SRC-PTK2B/PYK2 complex and SRC kinase activity are necessary for this function. Recruited to activated integrins by PTK2B/PYK2, thereby phosphorylating CBL, which in turn induces the activation and recruitment of phosphatidylinositol 3-kinase to the cell membrane in a signaling pathway that is critical for osteoclast function. Promotes energy production in osteoclasts by activating mitochondrial cytochrome C oxidase. Phosphorylates DDR2 on tyrosine residues, thereby promoting its subsequent autophosphorylation. Phosphorylates RUNX3 and COX2 on tyrosine residues, TNK2 on 'Tyr-284' and CBL on 'Tyr-731'. Enhances DDX58/RIG-I-elicited antiviral signaling. Phosphorylates PDPK1 at 'Tyr-9', 'Tyr-373' and 'Tyr-376' (By similarity). Phosphorylates BCAR1 at 'Tyr-132' (By similarity).
Subunit : Interacts with CDCP1, PELP1, TGFB1I1 and TOM1L2 (By similarity). Interacts with DDEF1/ASAP1 via its SH3 domain. Interacts with CCPG1. Interacts with the cytoplasmic domain of MUC1, phosphorylates it and increases binding of MUC1 with beta-catenin. Interacts with RALGPS1 via its SH3 domain. Interacts with CAV2 (tyrosine phosphorylated form). Interacts (via the SH3 domain and the protein kinase domain) with ARRB1; the interaction is independent of the phosphorylation state of SRC C-terminus. Interacts with FCAMR and PXN. Interacts with ARRB2. Interacts with ARRB1. Interacts with SRCIN1 (By similarity). Interacts with SRCIN1. Interacts with NDFIP2 and more weakly with NDFIP1. Interacts with PIK3CA and/or PIK3C2B, PTK2/FAK1, ESR1 (dimethylated on arginine) and FAK. Interacts (via SH2 and SH3 domain) with TNK2. Interacts (via protein kinase domain) with the tyrosine phosphorylated form of RUNX3 (via runt domain). Interacts with TRAF3 (via RING-type zinc finger domain). Interacts with DDX58, MAVS and TBK1. Interacts (via SH2 domain) with GNB2L1/RACK1; the interaction is enhanced by tyrosine phosphorylation of GNB2L1 and inhibits SRC activity (By similarity). Interacts (via SH2 domain) with the 'Tyr-402' phosphorylated form of PTK2B/PYK2. Interacts (via SH2 domain) with FLT3 (tyrosine phosphorylated). Identified in a complex containing FGFR4, NCAM1, CDH2, PLCG1, FRS2, SRC, SHC1, GAP43 and CTTN. Interacts with EPHB1; activates the MAPK/ERK cascade to regulate cell migration. Interacts with ERBB2 and STAT1. Interacts with PDGFRA (tyrosine phosphorylated). Interacts with CSF1R. Interacts (via SH2 domain) with the 'Tyr-9' phosphorylated form of PDPK1. Interacts with DDR2. Interacts with AMOTL2; this interaction regulates the translocation of phosphorylated SRC to peripheral cell-matrix adhesion sites. Interacts with DDR1 and DAB2. [INTERACTION] Q63767:Bcar1 (xeno); NbExp=2; IntAct=EBI-298680, EBI-1176801; P07141:Csf1; NbExp=2; IntAct=EBI-298680, EBI-777188; Q8T4F7:ena (xeno); NbExp=2; IntAct=EBI-298680, EBI-466810; P54763:Ephb2; NbExp=3; IntAct=EBI-298680, EBI-537711; P05106:ITGB3 (xeno); NbExp=5; IntAct=EBI-298680, EBI-702847; P49023:PXN (xeno); NbExp=2; IntAct=EBI-298680, EBI-702209; Q01973:ROR1 (xeno); NbExp=3; IntAct=EBI-298680, EBI-6082337; P70315:Was; NbExp=2; IntAct=EBI-298680, EBI-644195.
Subcellular Location : Cell membrane. Mitochondrion inner membrane. Nucleus. Cytoplasm, cytoskeleton. Note=Localizes to focal adhesion sites after integrin engagement. Localization to focal adhesion sites requires myristoylation and the SH3 domain.
Tissue Specificity : Expressed ubiquitously. Plaets, neurons and osteoclasts express 5-fold to 200-fold higher levels than most other tissues.
Post-translational modifications : Myristoylated at Gly-2, and this is essential for targeting to membranes (By similarity).
Dephosphorylated at Tyr-535 by PTPRJ (By similarity). Phosphorylated on Tyr-535 by c-Src kinase (CSK). The phosphorylated form is termed pp60c-src. Dephosphorylated by PTPRJ at Tyr-424. Normally maintained in an inactive conformation with the SH2 domain engaged with Tyr-535, the SH3 domain engaged with the SH2-kinase linker, and Tyr-424 dephosphorylated. Dephosphorylation of Tyr-535 as a result of protein tyrosine phosphatase (PTP) action disrupts the intramolecular interaction between the SH2 domain and Tyr-535, Tyr-424 can then become autophosphorylated, resulting in SRC activation. Phosphorylation of Tyr-535 by CSK allows this interaction to reform, resulting in SRC inactivation. CDK5-mediated phosphorylation at Ser-74 targets SRC to ubiquitin-dependent degradation and thus leads to cytoskeletal reorganization. Phosphorylated by PTK2/FAK1; this enhances kinase activity. Phosphorylated by PTK2B/PYK2; this enhances kinase activity (By similarity).
S-nitrosylation is important for activation of its kinase activity (By similarity).
Ubiquitinated in response to CDK5-mediated phosphorylation.
Similarity : Belongs to the protein kinase superfamily. Tyr protein kinase family. SRC subfamily.
Contains 1 protein kinase domain.
Contains 1 SH2 domain.
Contains 1 SH3 domain.
Database links : UniProtKB/Swiss-Prot: P05480.4
src原癌基因具有*激酶活性，參與調(diào)節(jié)正常細(xì)胞的生長與分化，在控制細(xì)胞增殖的信息轉(zhuǎn)導(dǎo)途徑中起作用；src原癌基因同樣有活化癌基因的作用，能夠誘導(dǎo)細(xì)胞的異常增殖和導(dǎo)致腫瘤發(fā)生。
英文名稱  Anti-SCG3/SgIII
中文名稱  分泌粒蛋白3抗體
別    名  Secretogranin 3; Secretogranin-3; SCG3; 1B1075; AI385542; Chgd; Secretogranin III; SGCG; SCG3_HUMAN; SgIII; SGIII.
濃    度  1mg/1ml
規(guī) 格  0.1ml/100μg  0.2ml/200μg
抗體來源  Rabbit 
克隆類型  polyclonal
交叉反應(yīng)  Human, Mouse, Rat, Chicken, Dog, Cow, Horse, Rabbit